NVO20260116C40
NVO Jan 16 2026 40.00 Call (NVO260116C00040000)
option OPRA

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.